Claiming not to be in competition with each other but rather with time and the coronavirus, top executives from the world's leading pharmaceutical companies said yesterday they're working as fast as they can to develop, scale up, and distribute a COVID-19 vaccine.At a media briefing organized by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), executives from AstraZeneca, GlaxoSmithKline, Johnson & Johnson, and Pfizer also said they were committed to making coronavirus vaccines safe and ensuring equitable access."We are deeply aware that no one can fight COVID-19/SARS-CoV-2 on their own," said IFPMA Director General Thomas Cueni, MS. "The industry is all in.""As we all know, we need a lot of options, as